The allure of tumor-released chemotactic factors beckons neutrophils to the tumor site, where tumor-associated neutrophils (TANs) can bolster CD8 + T cell responses and anti-tumor activity in the absence of tumor-derived TGF-β. The gene discussed is CD8A; the disease is neoplasm.